Z79.899 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM Z79.899 became effective on October 1, 2021. This is the American ICD-10-CM version of Z79.899 - other international versions of ICD-10 Z79.899 may differ.
Just a quick tip an irritated Neurologist once suggested to me, keep a binder with the following:
Z79.899 is a valid billable ICD-10 diagnosis code for Other long term (current) drug therapy. It is found in the 2022 version of the ICD-10 Clinical Modification (CM) and can be used in all HIPAA-covered transactions from Oct 01, 2021 - Sep 30, 2022. POA Exempt
Z09 is a billable diagnosis code used to specify a medical diagnosis of encounter for follow-up examination after completed treatment for conditions other than malignant neoplasm. The code Z09 is valid during the fiscal year 2022 from October 01, 2021 through September 30, 2022 for the submission of HIPAA-covered transactions.
The four appendices to the ICD-9-CM medical insurance diagnostic codes are:
ICD-10 Classifications The ICD-10 section that covers long-term drug therapy is Z79, with many subsections and specific diagnosis codes. Because Plaquenil does not have its own specific category, clinicians should use Z79. 899—Other Long Term (Current) Drug Therapy.
899 or Z79. 891 depending on the patient's medication regimen. That said, it was always a supporting diagnosis, never primary.
Z79. 899 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM Z79. 899 became effective on October 1, 2021.
v58. 69 is what we use for medication management.
ICD-10 code Z79. 899 for Other long term (current) drug therapy is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
Z79 Long-term (current) drug therapy. Codes from this category indicate a patient's. continuous use of a prescribed drug (including such. things as aspirin therapy) for the long-term treatment. of a condition or for prophylactic use.
A: Assign a code from Z79 if the patient is receiving a medication for an extended period as a prophylactic measure (such as for the prevention of deep vein thrombosis) or as treatment of a chronic condition (such as arthritis) or a disease requiring a lengthy course of treatment (such as cancer).
Even though ICD-10-CM does not provide a specific code for immunosuppressants, Z79. 899 is used to identify the immunosuppressant therapy.
ICD-10-CM Diagnosis Code Z79 Z79.
Encounter for therapeutic drug level monitoring. Z51. 81 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM Z51.
ICD-10 Code for Encounter for issue of repeat prescription- Z76. 0- Codify by AAPC.
Z codes may be used as either a first-listed (principal diagnosis code in the inpatient setting) or secondary code, depending on the circumstances of the encounter. Certain Z codes may only be used as first-listed or principal diagnosis.
The ICD-10-CM Alphabetical Index links the below-listed medical terms to the ICD code Z79.899. Click on any term below to browse the alphabetical index.
This is the official approximate match mapping between ICD9 and ICD10, as provided by the General Equivalency mapping crosswalk. This means that while there is no exact mapping between this ICD10 code Z79.899 and a single ICD9 code, V58.69 is an approximate match for comparison and conversion purposes.
Z79.899 is a valid billable ICD-10 diagnosis code for Other long term (current) drug therapy . It is found in the 2021 version of the ICD-10 Clinical Modification (CM) and can be used in all HIPAA-covered transactions from Oct 01, 2020 - Sep 30, 2021 .
DO NOT include the decimal point when electronically filing claims as it may be rejected. Some clearinghouses may remove it for you but to avoid having a rejected claim due to an invalid ICD-10 code, do not include the decimal point when submitting claims electronically. See also:
Z79. 899 is a billable code used to specify a medical diagnosis of other long term (current) drug therapy.
Encounter for therapeutic drug level monitoring. Z51. 81 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2020 edition of ICD-10-CM Z51.
Other long term (current) drug therapy 899 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2020 edition of ICD-10-CM Z79. 899 became effective on October 1, 2019.
Person consulting for explanation of examination or test findings. Z71. 2 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2020 edition of ICD-10-CM Z71.
The primary billing codes used are: 90862 – Defined as pharmacological management including prescription use and review of medication with no more than minimal psychotherapy. 90805 – Individual psychotherapy approximately 20 – 30 minutes face to face, with medical evaluation and management services.
Based on the statement in the record here, ' looking for consistent results...for the prescribed medications ', I would code Z51.81 - Encounter for therapeutic drug level monitoring - as the primary code, with the appropriate Z79- codes for the particular prescribed drugs that the patient is taking as secondary codes per the 'code also' note under Z51.81 for the testing. But codes for the pain conditions would also be appropriate if the record shows that is also being evaluated or managed at the same encounter.
When I coded pain management, this code was often a supporting diagnosis. I usually used whatever pain code was most accurate (m54.5, M79.7 etc, etc), followed by Z79.899 or Z79.891 depending on the patient's medication regimen. That said, it was always a supporting diagnosis, never primary. It might be okay for primary for drug testing or something of the sort.